Bipolar disorder I
Clinical trials for Bipolar disorder I explained in plain language.
Never miss a new study
Get alerted when new Bipolar disorder I trials appear
Sign up with your email to follow new studies for Bipolar disorder I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a dissolving film calm agitated teens? new trial begins
Symptom relief Recruiting nowThis early-stage trial tests BXCL501, a dissolving film placed under the tongue, to quickly reduce agitation in children and teens aged 10-17 with schizophrenia or bipolar disorder. About 140 participants will receive either the drug or a placebo. The study measures changes in ag…
Matched conditions: BIPOLAR DISORDER I
Phase 1 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Brain zaps may speed up thinking in psychosis
Knowledge-focused Recruiting nowThis study explores whether a non-invasive magnetic brain stimulation technique (TMS) can temporarily improve how quickly people with psychotic disorders (like schizophrenia or bipolar) solve problems. About 95 participants will do thinking tasks and get brain scans before and af…
Matched conditions: BIPOLAR DISORDER I
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
A nighttime hormone may hold the key to predicting Lithium's success
Knowledge-focused Recruiting nowThis study investigates whether the amount of melatonin produced at night differs between people with bipolar I disorder who respond well to lithium and those who do not. Researchers will collect urine and blood samples from 60 participants to measure melatonin and other biologic…
Matched conditions: BIPOLAR DISORDER I
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Blood inflammation may hold clues to psychiatric diagnosis
Knowledge-focused Recruiting nowThis study investigates whether markers of inflammation in the blood could serve as diagnostic or severity biomarkers across several psychiatric conditions, including bipolar disorder, schizophrenia, and depressive episodes with psychotic features. Researchers will collect blood …
Matched conditions: BIPOLAR DISORDER I
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC